KFDA reviews procurement system of ginkgo biloba extracts

Published: 2010-08-23 06:59:00

Updated: 2010-08-23 06:59:00

The Korea Food and Drug Administration has begun to review the procurement systems for ginkgo biloba extracts imported from China, a source said recently.

The drug agency has conducted an on-the-spot inspection of a manufacturing site in China, as Kukjeon filed an application for the product ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK